title: The current management of cystic fibrosis.
abstract: Cystic fibrosis (CF) is one of the commonest lethal inherited conditions among Caucasians. It affects multiple organ systems and exhibits a range of clinical problems of varying severity. Life expectancy has improved in recent years as treatment regimes have become more intensive, but current treatments are expensive, often time consuming and may affect quality of life. This review summarises the treatments currently used in the management of patients with CF, and the evidence for these.
authors.affiliation: Evidence Based Child Health Unit, Royal Liverpool Children's NHS Trust, Alder Hey, UK.
authors.forename: C M
authors.initials: CM
authors.lastname: Lees
authors.forename: R L
authors.initials: RL
authors.lastname: Smyth
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000150:complications / Q000534:rehabilitation / Q000628:therapy*; D005100:Expectorants / Q000008:administration & dosage; D006801:Humans; D018529:Nutritional Support; D026741:Physical Therapy Modalities / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D012131:Respiratory Insufficiency / Q000150:complications
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D005100:Expectorants